chemic
physic
agent
widespread
method
use
control
microorgan
physic
method
includ
radiat
heat
filtrat
destroy
erad
detriment
microorgan
nonion
ray
wavelength
longer
visibl
light
microbicid
wavelength
uv
ray
lie
rang
nm
nm
effect
uv
ray
gener
highpressur
mercuri
vapor
lamp
produc
wavelength
maxim
absorb
microorgan
caus
germicid
effect
uv
ray
induc
format
dimer
ultim
inhibit
dna
replic
nonleth
dose
uv
ray
even
induc
mutat
cell
uv
radiat
inactiv
microorgan
bacteria
virus
yeast
within
second
sinc
uv
ray
kill
spore
consid
use
surfac
disinfect
ioniz
ray
similar
prior
two
type
particul
electromagnet
ray
electron
beam
particul
natur
produc
highspe
electron
linear
acceler
heat
cathod
gamma
ray
electromagnet
natur
employ
steril
articl
like
syring
glove
dress
pack
food
pharmaceut
steril
achiev
second
moreov
instrument
switch
heat
anoth
easier
way
steril
exert
oxid
effect
well
denatur
coagul
protein
object
withstand
elev
temperatur
quiet
steril
lower
temperatur
extend
interv
exposur
two
type
heat
steril
dri
moist
heat
dri
heat
deed
protein
denatur
oxid
damag
toxic
effect
higher
level
electrolyt
moist
heat
crack
coagul
denatur
protein
moist
heat
effect
dri
heat
action
temperatur
necessari
extermin
microb
dri
heat
higher
moist
heat
minimum
time
requir
kill
suspens
organ
predetermin
temperatur
specifi
environ
known
thermal
death
time
laboratoryscal
cultur
temperatur
min
util
kill
spore
process
call
autoclav
filtrat
word
sens
separ
microb
instead
kill
membran
filter
pore
size
rang
frequent
use
elimin
particl
solut
nonautoclav
numer
applic
filtrat
contain
measur
size
virus
remov
bacteria
ingredi
cultur
media
separ
toxin
cultur
filtrat
count
prepar
suspens
virus
phage
free
bacteria
purifi
hydrat
fluid
clarifi
fluid
differ
type
filter
earthenwar
filter
membran
filter
sinter
glass
filter
asbesto
filter
well
air
filter
addit
antimicrobi
agent
chemic
rescind
pathogen
bacteria
inert
surfac
marzieh
et
al
process
like
dna
synthesi
mrna
transcript
cell
divis
requir
inton
chromosom
supercoil
strand
breakag
catalyz
topoisomeras
rejoin
respons
gellert
et
al
drlica
snyder
esp
marian
synthet
quinolon
class
antimicrobi
exploit
reaction
target
complex
sugino
et
al
gellert
et
al
drlica
et
al
quinolon
deriv
nalidix
acid
introduc
treat
urinari
tract
infect
byproduct
synthesi
chloroquin
quinin
hooper
rubnstein
nalidix
acid
firstgener
quinolon
eg
oxolin
acid
hardli
use
today
owe
toxic
wherea
second
ciprofloxacin
third
levofloxacin
fourth
gemifloxacin
gener
quinolon
antibiot
tabl
wide
market
classifi
basi
chemic
structur
qualit
differ
kill
mechan
execut
rubinstein
hooper
rubnstein
doublestrand
dna
break
caus
topoisomeras
inhibit
quinolon
induc
dna
stress
respons
so
respons
reca
stimul
dna
damag
encourag
selfcleavag
lexa
repressor
protein
persuad
express
so
respons
gene
dna
repair
enzym
courcel
hanawalt
enhanc
activ
quinolon
except
case
nalidix
acid
howard
et
al
prevent
activ
so
respons
also
display
decreas
develop
drugresist
mutant
hinder
gener
errorpron
dna
polymeras
criz
et
al
horizont
transfer
drugresist
element
guerin
et
al
homolog
recombin
owe
studi
illumin
cotreat
protein
synthesi
inhibitor
chloramphenicol
quinolon
inhibit
abil
quinolon
beaber
et
al
bacteri
cell
sheath
strata
peptidoglycan
also
known
murein
coval
crosslink
polym
matrix
compos
peptidelink
nacetyl
hexosamin
mechan
strength
afford
layer
cell
wall
crucial
bacterium
abil
endur
environment
condit
alter
preval
osmot
pressur
note
degre
peptidoglycan
crosslink
compar
structur
integr
cell
mainten
peptidoglycan
layer
accomplish
activ
transglycosylas
penicillinbind
protein
pbp
also
known
transpeptidas
add
disaccharid
pentapeptid
encompass
glycan
strand
exist
peptidoglycan
molecul
crosslink
adjac
peptid
strand
immatur
peptidoglycan
unit
respect
bugg
walsh
treatment
inhibitor
cell
wall
synthes
chang
induct
cell
stress
respons
cell
shape
size
ultim
cell
lysi
instanc
includ
penicillin
carbapenem
cephalosporin
wedg
crosslink
peptidoglycan
unit
obstruct
peptid
bond
format
reaction
catalyz
peptidoglycanbind
protein
pbp
wise
park
holtj
park
uehara
inhibit
achiev
penicilloyl
pbp
activ
site
contain
cyclic
amid
ring
analogu
termin
dalanyldalanin
dipeptid
peptidoglycan
penicilloyl
pbp
activ
site
block
hydrolysi
bond
creat
ringopen
drug
therebi
disabl
enzym
waxman
et
al
josephin
et
al
autolysi
use
autolysin
autolysin
membraneassoci
enzym
break
bond
peptidoglycan
strand
autolysin
also
display
show
part
lytic
cell
death
bacteri
speci
contain
numer
peptidoglycan
hydrolas
e
coli
tipper
stroming
e
coli
set
put
peptidoglycan
hydrolas
lytm
domain
factor
shown
import
rapid
ampicillinmedi
lysi
uehara
et
al
discoveri
autolysin
contribut
cell
death
expand
understand
lysi
show
activ
degrad
peptidoglycan
inhibit
peptidoglycan
synthesi
antibiot
trigger
lysi
streptococcu
pneumonia
lack
peptidoglycan
hydrolas
activ
still
kill
slower
rate
autolysinact
cell
indic
lysisindepend
mode
kill
induc
moreillon
et
al
hoch
novak
et
al
instanc
staphylococcu
aureu
lytsr
twocompon
system
affect
cell
lysi
modifi
autolysin
activ
burnskil
bayl
lytr
trigger
manifest
lrgab
found
imped
autolysin
activ
therebi
lead
antibiot
toler
lrga
similar
bacteriophag
holin
protein
groicher
et
al
control
access
autolysin
peptidoglycan
layer
base
evid
supplementari
holinlik
system
cidab
uncov
aureu
initi
activ
autolysin
repres
aureu
suscept
kill
complement
cida
cidanul
strain
invert
damag
autolysin
activ
wholli
reinstat
sensit
rice
et
al
handl
lead
variat
cell
morpholog
accompani
primari
interact
gener
speak
inhibitor
sourc
cell
elong
strong
activ
lysi
inhibitor
chang
cell
shape
lyse
inhibitor
impact
cell
divis
persuad
filament
spratt
accordingli
also
effect
induc
peptidoglycan
hydrolas
activ
inhibitor
least
profici
autolysin
activ
kitano
tomasz
mrna
translat
process
occur
three
sequenti
phase
initi
elong
termin
compris
ribosom
rang
cytoplasm
accessori
factor
garrett
ribosom
compos
two
ribonucleoprotein
subunit
assembl
initi
phase
follow
format
complex
mrna
transcript
nformylmethioninecharg
aminoacyl
trna
sever
initi
factor
free
subunit
drug
inhibit
protein
synthesi
among
biggest
class
antibiot
divid
two
subclass
inhibitor
inhibitor
tabl
ribosom
inhibitor
includ
lincosamid
eg
clindamycin
macrolid
eg
erythromycin
streptogramin
eg
quinupristin
amphenicol
eg
chloramphenicol
oxazolidinon
eg
linezolid
nissen
et
al
katz
ashley
ribosom
inhibitor
work
physic
block
access
aminoacyltrna
ribosom
either
initi
protein
translat
case
oxazolidinon
patel
et
al
among
ribosom
inhibitor
class
broadli
bactericid
natur
deriv
aminoglycosid
macrolid
streptogramin
spectinomycin
tetracyclin
chloramphenicol
macrolid
typic
bacteriostat
howev
bactericid
speci
treatmentspecif
manner
even
though
antibiot
prevent
measur
bacteri
growth
excit
scientif
commun
exhibit
phenomenon
call
microbi
resist
result
portent
microb
develop
surviv
even
antibiot
administ
point
get
mutat
becom
resist
antibiot
come
across
earlier
lifetim
come
applic
nanoparticl
np
carrier
antibioticsa
replac
antibiot
mani
np
usual
counteract
least
one
common
resist
mechan
possess
effect
bactericid
mode
np
base
specif
physicochem
properti
chen
et
al
uniqu
small
size
help
np
interact
cell
due
larger
surfac
areatomass
ratio
handi
manag
applic
contrast
tradit
antibiot
besid
interrupt
bacteri
membran
difficulti
biofilm
format
anoth
signific
mechan
portray
major
measur
progress
bacteri
resist
peulen
wilkinson
distinct
structur
arrang
bacteri
biofilm
deliv
protect
implant
microorgan
assist
escap
antibiot
moreov
bacteri
biofilm
breed
ground
regular
resist
mutat
interchang
variat
mutat
among
divers
bacteri
cell
khameneh
et
al
studi
reveal
mani
np
prevent
overcom
biofilm
format
includ
aubas
np
yu
et
al
np
cuo
np
miao
et
al
agbas
np
markowska
et
al
zno
np
mgbase
np
lellouch
et
al
np
hetrick
et
al
slomberg
et
al
yf
np
lellouch
et
al
better
prevent
biofilm
attain
lesser
size
larger
surfac
areatomass
ratio
well
particl
shape
np
extraordinari
outcom
biofilm
destruct
eg
np
rodlik
shape
oper
np
spheric
shape
antimicrobi
mechan
tradit
antibiot
modest
owe
bacteria
develop
resist
dispar
tradit
antibiot
np
combat
microb
via
multipl
mechan
simultan
activ
advantag
simultan
mechan
even
though
microb
multipl
mutat
gene
np
assist
reduc
microbi
resist
np
combat
bacteri
microbi
resist
mention
earlier
also
act
medium
carrier
antibiot
howev
mechan
npbase
drug
deliveri
differ
present
earlier
govern
smaller
size
np
appropri
accompani
antimicrobi
oper
fight
intracellular
bacteria
ranghar
manag
infect
caus
intracellular
strain
drug
resist
multifari
use
antibiot
andrad
et
al
qi
et
al
antibiot
reduc
membran
transport
drug
ordinari
size
less
influenc
intracellular
microb
improv
treatment
method
use
drugload
np
mediat
project
overcom
limit
np
carrier
aid
rise
serum
level
antibiot
shield
drug
resist
target
bacteria
within
np
carrier
drug
shelter
harm
chemic
reaction
maintain
potenc
drug
moreov
better
efflux
reduc
uptak
antibiot
bacteri
cell
p
aeruginosa
e
coli
normal
signific
reason
resist
tradit
antibiot
howev
research
prove
numer
np
incredul
mechan
muhl
et
al
prevent
drug
resist
exampl
gastrointestin
tract
dendrim
inhibit
pglycoproteinmedi
efflux
liu
et
al
np
carrier
minim
system
side
effect
target
antibiot
infect
site
use
carrier
reduc
side
effect
includ
drug
toxic
encourag
highdos
drug
absorpt
desir
site
npbase
antibacteri
drug
deliveri
system
deliv
drug
site
action
therefor
reduc
side
effect
target
npbase
drug
deliveri
entail
activ
target
passiv
target
activ
target
achiev
np
surfac
modif
allow
npbase
drug
deliveri
system
select
identifi
precis
ligand
cell
site
infect
passiv
target
achiev
improv
permeat
retain
infect
site
activ
target
embrac
receptor
target
temperatur
target
magnet
target
xiong
et
al
control
sustain
discharg
antibiot
attain
docil
convent
deliveri
method
blood
drug
level
maintain
short
time
lowest
effect
dose
consequ
frequent
dose
obligatori
lead
side
effect
appropri
np
carrier
method
drug
releas
blood
concentr
medicin
infect
site
persist
compulsori
effect
level
long
time
occas
good
stabil
compact
frequenc
medic
enhanc
patient
complianc
condens
patient
pain
along
prolong
drug
releas
liu
et
al
np
effect
even
differ
type
govern
stimulatori
factor
magnet
field
chemic
agent
light
heat
ph
lim
et
al
wu
et
al
baig
et
al
mani
drug
packag
within
np
assist
construct
increas
agent
antibacteri
properti
concurr
combin
dissimilar
drug
help
develop
effici
due
joint
action
multipl
mechan
hand
two
type
np
use
combin
improv
antibacteri
effect
prevent
resist
liu
et
al
fusion
np
maxim
power
diminish
weak
individu
type
np
exampl
studi
shown
superior
efficaci
vivo
cellular
deliveri
achiev
hybrid
np
compar
deliveri
without
polymer
np
liposom
hadinoto
et
al
effect
express
decreas
possibl
growth
bacteri
resist
brook
brook
abovement
advantag
may
unit
divers
combin
differ
emphas
process
actual
applic
recent
studi
reveal
size
np
great
role
bioactiv
length
diamet
nanotub
attun
anod
oxid
process
paramet
increas
releas
time
drug
nanotub
silica
np
administ
syneret
composit
film
antibacteri
activ
result
size
nanotub
basic
dog
amount
machineri
activ
smaller
np
larger
specif
surfac
area
result
larger
permeabl
cell
membran
gurunathan
et
al
deplanch
et
al
shape
also
account
antimicrobi
activ
np
interact
periplasm
enzym
caus
vari
gradat
bacteri
cell
damag
respect
shape
np
cha
et
al
comparison
zno
np
pyramid
plate
sphere
shape
show
arrang
gal
shapespecif
zno
np
produc
photocatalyt
activ
prasannakumar
et
al
pseudomona
desmolyticum
aureu
greatli
affect
prismaticshap
np
due
direct
interact
np
surfac
bacteri
cell
membran
hong
et
al
moreov
cubeshap
agnp
exhibit
stronger
antibacteri
activ
sphereshap
wireshap
agnp
similar
diamet
due
specif
surfac
area
facet
reactiv
acti
et
al
lesser
effect
microbiota
suscept
talebian
sadeghi
rough
also
act
factor
respect
antibacteri
action
rough
np
increas
size
surfac
areatomass
ratio
promot
adsorpt
bacteri
protein
follow
reduct
bacteri
adhes
sukhorukova
et
al
recent
studi
valid
zeta
potenti
np
durabl
influenc
bacteri
adhes
electrostat
attract
among
posit
charg
np
bacteri
neg
charg
cell
membran
posit
surfac
charg
prone
adsorb
bacteri
surfac
meticul
connect
bacteria
contrast
neg
charg
counterpart
pan
et
al
rise
vascular
permeabl
maeda
limit
bacteri
attach
ion
exchang
fang
et
al
comparison
neg
charg
neutral
np
posit
charg
counterpart
believ
enhanc
ro
product
lead
interact
np
bacteri
surfac
arakha
et
al
np
use
clinic
alter
aggreg
use
dope
modif
techniqu
allow
np
dispers
hydrophil
aqueou
environ
dope
modif
also
one
oper
method
normal
regul
interact
np
bacteria
late
zno
np
au
gold
combin
form
znoau
nanocomposit
administ
improv
photocatalyt
activ
enhanc
ro
gener
effect
result
follow
factor
alter
zno
bandwidth
better
light
absorpt
owe
surfac
plasmon
reson
wavelength
au
enhanc
photoinduc
charg
carrier
reactiv
amplifi
electron
transport
effici
carrier
charg
separ
et
al
instanc
zno
np
dope
fluorin
gener
ro
zno
np
result
greater
damag
bacteri
cell
guo
et
al
podsporka
et
al
zno
np
content
surfac
regul
antimicrobi
effect
gramposit
gramneg
bacteria
mehmood
et
al
reduc
format
biofilm
dental
implant
show
greater
antimicrobi
action
comparison
unmodifi
increas
photocatalyt
activ
dope
form
effect
extend
activ
spectrum
visibl
light
region
valenc
bandwidth
elev
forbidden
bandwidth
depriv
peng
et
al
sangari
et
al
variou
environment
condit
display
signific
differ
antimicrobi
activ
exampl
temperatur
environ
potenti
influenc
antibacteri
activ
follow
effect
ro
gener
rate
zno
np
encourag
temperatur
electron
detain
activ
site
afterward
electron
interact
oxygen
molecul
ro
gener
therebi
increas
antimicrobi
effect
zno
np
decreas
ph
increas
rate
dissolut
zno
np
elev
antimicrobi
properti
saliani
et
al
addit
acid
condit
injuri
abil
poli
lacticcoglycol
acid
plga
poli
lhistidin
plh
poli
ethylen
glycol
peg
encapsul
vancomycin
deceas
select
certain
result
propos
proton
imidazol
group
plh
select
acid
condit
intens
influenc
np
surfac
charg
switch
surfac
np
charg
posit
low
ph
becom
benefici
interact
neg
charg
group
bacteri
cell
barrier
prompt
multival
strong
electrostat
regul
radov
et
al
anoth
studi
propos
interact
ag
dissolv
oxygen
proton
caus
oxid
dissolut
mechan
agnp
could
activ
agnp
releas
mani
ag
ion
enhanc
antibacteri
activ
agnp
acet
acid
neutral
water
peretyazhko
et
al
cultur
medium
characterist
osmot
pressur
ph
influenc
aggreg
surfac
charg
solubl
np
antibacteri
test
five
type
media
demonstr
antimicrobi
activ
zno
np
mainli
due
free
zn
ion
zinc
complex
furthermor
medium
suppli
nutrient
bacteria
improv
toler
np
li
et
al
final
studi
shown
prepar
zno
np
differ
stir
condit
affect
antibacteri
activ
gramposit
b
subtili
gramneg
e
coli
bacteria
fungu
c
albican
khan
et
al
presenc
core
intuit
attribut
antimicrobi
activ
research
agnp
inclin
accumul
bacteri
membran
form
aggreg
put
connect
bacteria
caus
perfor
lead
cellular
death
li
et
al
howev
differ
size
nm
sever
hundr
nm
also
interact
action
mechan
biolog
compon
agnp
surfac
particl
size
propos
action
mechan
slightli
without
secondari
speci
agnp
gener
cytotox
action
inactiv
enzym
bacteria
produc
reactiv
oxygen
speci
kim
ryu
mechan
give
preval
role
ag
speci
system
contain
initi
silver
speci
releas
ro
simpl
dissolut
ion
exchang
salt
valentin
et
al
zeolit
sambhi
et
al
ionom
dalla
et
al
happen
metal
nanoparticl
thu
monoval
silver
speci
becom
antibacteri
agent
keep
np
reservoir
silver
ion
possess
affin
toward
organ
notabl
thiol
form
quasicoval
bond
bind
energi
around
kcalmol
amin
phosphat
affin
ag
selenol
group
analog
han
et
al
moieti
fairli
uncommon
live
world
furthermor
silver
act
link
agent
sever
thiol
form
aggreg
thiolcontain
molecul
irrevers
parikh
et
al
sever
molecul
dna
peptid
membranebound
insid
cell
cofactor
recogn
target
ion
observ
die
bacteria
contrast
antibiot
target
one
particular
constitu
bacteri
life
cycl
ag
ion
adsorb
voluntarili
high
affin
moieti
thu
unlik
mani
pathway
affect
caus
cellular
death
much
probabl
hypothesi
would
silver
bind
nonspecif
wide
varieti
target
perturb
simultan
mani
aspect
cell
metabol
lead
death
among
pathway
affect
sensit
littl
amount
silver
speci
capabl
disrupt
larg
varieti
pathway
may
one
reason
explain
antibacteri
action
silver
nanoparticl
broad
spectrum
microorgan
park
et
al
present
develop
ro
intric
half
antibacteri
activ
compar
ag
action
presenc
absenc
oxygen
respir
releas
chemisorb
ion
surfac
particl
along
oxid
anoth
sourc
ag
ion
nanoparticul
system
dobia
berrier
percentag
novel
silver
salt
remain
oxid
compar
even
mild
reduc
agent
sodium
citrat
ad
solut
remain
free
solut
bound
surfac
nanoparticl
group
pend
citrat
ligand
henglein
chlorid
much
avail
environment
biolog
system
form
slightli
solubl
precipit
agcl
howev
presenc
excess
chlorid
solubl
silver
polychlorid
speci
agclx
x
form
contribut
antibacteri
activ
chamber
et
al
levard
et
al
size
shape
depend
nanoparticl
also
contribut
releas
ag
ion
requir
dissolv
agnp
pal
et
al
zhang
et
al
improv
activ
occur
due
larger
surfac
per
unit
mass
scale
like
number
particl
scale
like
surfac
like
r
radiu
minor
np
reveal
activ
surfac
thu
prone
dissolut
analog
reason
accumul
np
uncov
smaller
amount
surfac
solvent
separ
np
possess
lesser
antibacteri
impact
bae
et
al
howev
recent
valid
liu
et
al
releas
ag
scale
well
sampl
regular
expos
surfac
afterward
xiu
et
al
show
substanti
paramet
evalu
activ
silver
nanoparticl
silver
releas
ag
quantiti
primari
silver
ad
nanoparticl
fig
solut
phytosynthes
agnp
urtica
dioica
explor
antibacteri
activ
rang
pathogen
microorgan
jyoti
et
al
inhibit
zone
diamet
millimet
present
fig
tabl
agnp
unveil
higher
activ
solut
leav
extract
serv
control
moreov
antibacteri
activ
found
augment
higher
concentr
agnp
present
studi
zone
inhibit
found
highest
mm
marcescen
lowest
mm
k
pneumonia
find
agreement
previou
studi
examin
antibacteri
activ
agnp
ghosh
et
al
howev
mechan
inhibitori
action
metal
nanoparticl
microorgan
still
clearli
known
need
research
assist
recent
research
field
mani
applic
gold
np
au
np
start
engin
medicin
attribut
patra
et
al
biocompat
gold
nanoparticl
made
fit
enough
use
treatment
arthriti
cancer
jain
et
al
antimicrobi
therapi
darkfield
lightscatt
microscopi
au
np
sens
endocytosi
tumor
metabolit
receptor
cell
dykman
khlebstov
au
npbase
diagnost
kit
clinic
trial
kumar
et
al
greensynthes
au
np
fig
also
use
develop
quantif
blood
glucos
biosensor
toxic
metal
diseas
marker
insecticid
liu
lu
au
np
also
potenti
degrad
detoxifi
toxic
pollut
lopez
et
al
et
al
applic
shown
fig
mani
decad
gold
use
treatment
mani
tradit
medicin
robert
koch
first
explor
biocid
potenti
gold
djuran
apart
applic
due
abil
electrostat
flux
across
membran
result
distort
membran
antimicrobi
activ
au
np
typic
oppress
li
et
al
moreov
nanoparticl
also
improv
mani
gene
express
serv
redox
process
lead
microbi
death
nagi
et
al
smaller
size
distinct
surfac
chemistri
phototherm
natur
polyval
gu
et
al
gopinath
et
al
reaction
au
np
sulfur
phosphorushold
base
lead
inactiv
enzym
nicotinamid
adenin
dinucleotid
nadh
dehydrogenas
interrupt
respiratori
chain
high
amount
free
radic
gener
caus
cell
death
anoth
propos
hypothesi
np
declin
atpas
activ
gnp
may
also
prevent
trna
bind
ribosom
subunit
cui
et
al
instanc
leishmaniasi
au
np
produc
elev
electron
number
yield
ro
ro
may
even
abolish
dna
cellular
compon
pathogen
anoth
possibl
mechan
au
np
obstruct
h
efflux
transmembran
antimicrobi
potenti
mani
np
determin
size
surfac
chemistri
accord
herdt
et
al
state
gold
surfac
attach
lead
dna
degrad
brayner
et
al
herdt
et
al
moreov
accord
ahmad
et
al
nm
au
np
could
confin
h
transmembran
efflux
candida
speci
nm
au
np
moreov
antimicrobi
activ
also
differ
accord
cell
wall
composit
well
evidenc
au
np
highest
activ
gramneg
bacteria
gramposit
bacteria
due
composit
differ
describ
earlier
section
cell
wall
structur
bacteria
surfac
modif
coat
cap
agent
concentr
purif
method
also
affect
antibacteri
activ
zhang
et
al
kaviya
et
al
antibacteri
activ
efficaci
au
np
enhanc
antibiot
coat
especi
aminoglycosid
antibiot
payn
et
al
interest
compar
greensynthes
au
np
chemic
synthes
au
np
show
effectu
antibacteri
activ
certain
bacteri
strain
may
due
synergist
effect
au
np
extract
mishra
et
al
recent
apart
zno
use
wide
bandgap
semiconductor
ev
potenti
electron
applic
baxter
aydil
wide
rang
nanostructur
make
zno
nanoscal
optoelectron
piezoelectr
nanogener
song
et
al
use
power
fight
microorgan
sawai
et
al
report
sawai
et
al
consid
reveal
conductometr
method
consider
antibacteri
activ
cao
mgo
zno
attribut
gener
reactiv
oxygen
speci
surfac
oxid
zno
destroy
cell
membran
znonp
remain
forc
adsorb
dead
bacteria
surfac
prevent
antibacteri
action
continu
releas
peroxid
medium
show
high
bactericid
efficaci
result
anoth
studi
stoimenov
et
al
observ
smaller
particl
size
enhanc
activ
due
larg
surfac
areatovolum
ratio
thorough
mechan
znonp
activ
still
studi
antifung
activ
np
less
explor
compar
antibacteri
activ
gajbhiy
et
al
report
efficaci
biosynthes
silver
nanoparticl
p
glomerata
p
herbarum
trichoderma
sp
f
semitectum
c
albican
moreov
furthermor
describ
synergist
properti
blend
fluconazol
jo
et
al
deliber
activ
nanoparticl
silver
ion
two
plant
pathogen
fungi
magnaporth
grisea
bipolari
sorokiniana
antifung
activ
np
arrang
dissimilar
heterocycl
compound
like
thiazolidin
pyrazolo
phthalazin
hydrazid
tetrazolo
pyridazin
deriv
consid
c
albican
aspergillu
flavu
nasrollahi
et
al
investig
antifung
activ
chemic
synthes
agnp
c
albican
cerevisia
explain
potenti
activ
agnp
compar
standard
antifung
agent
viz
amphotericin
b
fluconazol
pawan
et
al
augment
potenti
antifung
activ
chitosan
nanoparticl
r
solani
flavu
alternata
chickpea
seed
anoth
studi
tile
bholay
report
signific
activ
agnp
trichophyton
rubrum
c
albican
fumigatu
extens
studi
xu
et
al
evalu
agnp
natamycin
strain
fungi
demonstr
higher
activ
compar
natamycin
one
possibl
explan
destruct
membran
integr
fungi
inhibit
normal
bud
process
yeast
kim
et
al
np
establish
marvel
care
antibacteri
activ
antivir
properti
metal
nanoparticl
continu
emerg
area
galdiero
et
al
best
known
exampl
west
nile
viru
sar
coronaviru
hantaviru
monkeypox
viru
nipah
viru
chikungunya
viru
hendra
viru
last
least
threat
pandem
influenza
virus
recent
avian
swine
origin
howard
fletcher
thu
greater
develop
novel
uniqu
cure
antivir
agent
incredul
issu
antivir
resist
instanc
agnp
develop
one
remedi
administr
viral
diseas
due
possibl
antivir
activ
requir
mainten
longlast
therapeut
regimen
circul
drug
concentr
three
key
aspect
extrapol
studi
conduct
far
antivir
properti
np
np
valid
antivir
activ
mani
virus
affect
prokaryot
degussem
et
al
narasimha
eukaryot
organ
make
true
broadspectrum
antivir
agent
viral
inhibit
even
reli
size
np
speshock
et
al
earli
infect
might
gener
time
frame
np
exert
antivir
activ
impos
rest
viral
replic
cycl
barampinto
et
al
trefri
wooley
howev
exact
mechan
np
antivir
activ
particular
phase
infect
np
exert
antivir
activ
yet
reveal
surpris
note
mani
antibacteri
mechan
np
still
uncertain
instanc
mani
studi
point
antibacteri
activ
rosoxid
stress
wherea
np
mgo
np
antibacteri
mechan
may
relat
regul
metabol
bacteri
strain
therefor
antibacteri
mechan
np
substanti
relev
address
futur
research
lack
cohes
standard
one
limit
exist
studi
antibacteri
mechan
np
particular
differ
bacteri
strain
np
characterist
action
time
examin
differ
studi
make
difficult
compar
antibacteri
activ
thu
solitari
method
accomplish
situat
procur
evid
antibacteri
mechan
np
type
np
exhibit
distinct
antibacteri
effect
complet
analysi
often
suggest
studi
probabl
antibacteri
mechan
limit
multifacet
bacteri
cell
membran
structur
defici
research
method
vitro
studi
furthermor
vitro
model
complet
sham
vivo
situat
precis
replic
cellular
bodi
interact
therefor
intoler
apprais
antibacteri
action
np
sole
vitro
bacteri
cell
cultur
regard
nanoneurotox
like
cross
np
across
bacteri
cell
membran
mani
question
still
unansw
research
commun
cell
membran
bacteri
barrier
channel
movement
substanc
bacteri
cell
membran
especi
gramneg
strain
porin
allow
passag
molecul
around
da
molecular
weight
across
bacteri
cell
bodi
therefor
due
size
almost
transport
nearli
np
limit
howev
certain
scholar
project
porin
facilit
passag
np
thick
rang
nm
bacteri
cell
membran
endocytosi
microorgan
similar
observ
eukaryot
cell
may
measur
addit
mechan
np
movement
era
increas
mdr
np
feasibl
altern
antibiot
seem
great
potenti
resolv
difficulti
bacteria
evolv
resist
numer
antibiot
type
becom
hard
combat
infecti
diseas
treat
patient
lead
seriou
mortal
mention
research
face
great
difficulti
design
apt
np
drug
antimicrobi
therapi
henc
develop
idea
antibiotictag
np
reduc
mdr
side
effect
accordingli
kumar
cowork
analyz
synergist
effect
agnp
eight
antibiot
pathogen
bacteria
fig
tabl
mani
case
could
analyz
effect
antibiot
enhanc
synergist
interact
agnp
streptomycin
show
minut
increas
inhibit
zone
seven
pathogen
bacteria
rang
except
b
cereu
increas
seen
combin
kanamycin
amikacin
tetracyclin
cefetaxim
agnp
show
compar
synergi
increas
amoxicillin
depict
highest
overal
synergist
activ
marcescen
vancomycin
agnp
reveal
synergist
activ
e
coli
greater
fold
increas
case
inhibit
zone
initi
epidermidi
b
subtili
e
coli
exist
blend
cefepim
agnp
epidermidi
marcescen
e
coli
typhimurium
klebsiella
pneumonia
marcescen
b
subtili
found
subdu
combin
agnp
antibiot
otherwis
indic
resist
pattern
manifest
antibiot
vancomycin
cefetaxim
ampicillin
kanamycin
amikacin
cefepim
alon
thu
could
augment
agnp
enhanc
efficaci
compani
antibiot
mani
drugresist
bacteria
fayaz
et
al
ghosh
et
al
singh
et
al
moreov
research
provid
help
insight
develop
new
antibacteri
agent
combin
antibiot
np
make
difficult
pathogen
bacteria
develop
resist
otherwis
render
avail
antibiot
ineffici
henc
combin
therapi
studi
develop
new
formul
np
synergi
antibiot
nanoparticl
manifold
applic
numer
field
scienc
electron
probe
diseas
diagnost
treatment
remedi
imag
cellular
transport
variou
physicochem
method
use
synthes
np
biogen
reduct
salt
produc
np
inexpens
safe
ecofriendli
furthermor
np
desir
morpholog
size
also
synthes
massiv
amount
process
reduct
potenti
stabil
endors
bioactiv
molecul
exist
biolog
resourc
among
bioreduct
plant
extract
advantag
biolog
resourc
therefor
prospect
use
plant
sourc
np
synthesi
open
new
horizon
futur
antibacteri
action
well
develop
microbi
resist
rule
mani
mean
mani
nanomateri
howev
sever
preclin
clinic
trial
research
level
better
consider
visual
restrict
well
potenti
mani
nanoparticl
elucid
antimicrobi
mechan
metallonanoparticl
tabl
summar
potenti
applic
nanoparticl
receiv
attent
research
unlik
antibiot
may
one
mechan
action
nanomateri
relat
multipl
cell
process
owe
potenti
applic
fight
multidrugresist
microorgan
explor
revolution
microbiolog
world
laboratori
commerci
scale
represent
studi
possibl
effect
ceria
convent
nanoparticl
bacteri
lipid
bilay
cytoplasm
follow
damag
cell
wall
peptidoglycan
layer
caus
direct
contact
nanoparticl
releas
toxic
ion
damag
proton
efflux
bomb
seriou
problem
ph
regul
modif
membran
charg
gener
reactiv
oxygen
speci
ro
damag
biolog
system
degrad
cell
wall
reactiv
oxygen
speci
ro
degrad
dna
rna
protein
also
interfer
protein
synthesi
low
adenosintriphosphat
atp
product
due
acidif
mechan
reactiv
oxygen
speci
ro
presenc
mechan
courtesi
formatex
